1. Home
  2. BCML vs LUNG Comparison

BCML vs LUNG Comparison

Compare BCML & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$30.01

Market Cap

348.1M

Sector

Finance

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.26

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
LUNG
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.1M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BCML
LUNG
Price
$30.01
$2.26
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$32.00
$6.81
AVG Volume (30 Days)
21.9K
1.0M
Earning Date
01-22-2026
11-12-2025
Dividend Yield
3.85%
N/A
EPS Growth
N/A
N/A
EPS
2.10
N/A
Revenue
$94,896,000.00
$91,664,000.00
Revenue This Year
$0.51
$9.21
Revenue Next Year
$10.33
$5.03
P/E Ratio
$14.75
N/A
Revenue Growth
N/A
15.59
52 Week Low
$22.22
$1.31
52 Week High
$33.15
$9.37

Technical Indicators

Market Signals
Indicator
BCML
LUNG
Relative Strength Index (RSI) 46.40 54.78
Support Level $30.73 $2.16
Resistance Level $33.15 $2.65
Average True Range (ATR) 1.11 0.20
MACD -0.16 -0.02
Stochastic Oscillator 37.43 45.71

Price Performance

Historical Comparison
BCML
LUNG

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: